Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New 5-FU molecular combination merits further study

June 7, 1996

Development of AccuSite for basal cell carcinoma delayed

June 7, 1996

Protein farnesyltransferase inhibitor from Banyu and Merck & Co.

May 31, 1996

Walter Reed Army Institute technology licensed to Jenner Technologies

May 31, 1996

Sandoz reports complex for radiotherapy of somatostatin receptor-positive cancers

May 31, 1996

OC104-26 identified as multidrug resistance (MDR)-reversing agent

May 31, 1996

ISIS-7597, an antisense oligonucleotide, shows promise in battling multidrug resistance

May 31, 1996

A highly lipophilic delta7-PGAI analogue, TEI-9826, demonstrates antitumor activity

May 31, 1996

Sulfone metabolite of sulindac induces apoptosis

May 31, 1996

C225 shows absence of dose-limiting toxicity

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...